Top

Published in:

01-02-2015 | CUTTING EDGE IN AUTOIMMUNITY

The epidemiological profile of ASIA syndrome after HPV vaccination: an evaluation based on the Vaccine Adverse Event Reporting Systems

Authors: Paolo Pellegrino, Valentina Perrone, Marco Pozzi, Carla Carnovale, Cristiana Perrotta, Emilio Clementi, Sonia Radice

Published in: Immunologic Research | Issue 1-2/2015

Abstract

The term “ASIA—Autoimmune/inflammatory Syndrome Induced by Adjuvants” describes an umbrella of clinical conditions sharing similar signs or symptoms, including post-vaccination phenomena. No information is available on the epidemiology of the ASIA syndrome, especially following HPV vaccination. We carried out an analysis of the VAERS database to retrieve all cases of suspected ASIA syndrome according to the Shoenfeld and Agmon-Levin’s guideline for the diagnosis. After causality assessment and case validation, 2,207 cases were considered probably or possibly related to vaccination. These represent the largest ASIA cohort ever reported and allowed us to estimate epidemiological and clinical characteristic of this syndrome. The commonest clinical manifestation observed were pyrexia (58 %), myalgia (27 %) and arthralgia or arthritis (19 %), and the estimated reporting rate was of 3.6 cases per 100,000 doses of HPV vaccine distributed (95 % CI 3.4–3.7). This study presents the first systematic estimation of ASIA incidence and expands the knowledge on this pathology. Further analyses are needed to identify genetic and non-genetic risk factors for ASIA syndrome.

Shoenfeld Y, Agmon-Levin N. ‘ASIA’: autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun. 2011;36(1):4–8. doi:10.1016/j.jaut.2010.07.003.PubMedCrossRef

Meroni PL. Autoimmune or auto-inflammatory syndrome induced by adjuvants (ASIA): old truths and a new syndrome? J Autoimmun. 2011;36(1):1–3. doi:10.1016/j.jaut.2010.10.004.PubMedCrossRef

Carvalho JF, Barros SM. ASIA or Shoenfeld’s syndrome: a novel autoimmune syndrome? Rev Bras Reumatol. 2010;50(5):487–8.PubMedCrossRef

Carvalho JF, Barros SM, Branco JC, Fonseca JE. Asia or Shoenfeld’s syndrome: highlighting different perspectives for diffuse chronic pain. Acta Reumatol Port. 2011;36(1):10–2.PubMed

Agmon-Levin N, Hughes GR, Shoenfeld Y. The spectrum of ASIA: ‘Autoimmune (Auto-inflammatory) Syndrome induced by Adjuvants’. Lupus. 2012;21(2):118–20. doi:10.1177/0961203311429316.PubMedCrossRef

Perricone C, Shoenfeld Y. Hepatitis B vaccination and undifferentiated connective tissue disease: another brick in the wall of the autoimmune/inflammatory syndrome induced by adjuvants (Asia). J Clin Rheumatol. 2013;19(5):231–3. doi:10.1097/RHU.0b013e31829d56f1.PubMedCrossRef

Toubi E. ASIA-autoimmune syndromes induced by adjuvants: rare, but worth considering. Isr Med Assoc J. 2012;14(2):121–4.PubMed

Zafrir Y, Agmon-Levin N, Paz Z, Shilton T, Shoenfeld Y. Autoimmunity following hepatitis B vaccine as part of the spectrum of ‘Autoimmune (Auto-inflammatory) Syndrome induced by Adjuvants’ (ASIA): analysis of 93 cases. Lupus. 2012;21(2):146–52. doi:10.1177/0961203311429318.PubMedCrossRef

Pellegrino P, Carnovale C, Perrone V, Antoniazzi S, Pozzi M, Clementi E, et al. No evidence of a link between multiple sclerosis and the vaccine against the human papillomavirus. Eur J Epidemiol. 2013;28(8):705–7. doi:10.1007/s10654-013-9830-y.PubMedCrossRef

10.

Pellegrino P, Carnovale C, Pozzi M, Antoniazzi S, Perrone V, Salvati D, et al. On the relationship between human papilloma virus vaccine and autoimmune diseases. Autoimmun Rev. 2014;13(7):736–41. doi:10.1016/j.autrev.2014.01.054.PubMedCrossRef

11.

Perricone C, Agmon-Levin N, Valesini G, Shoenfeld Y. Vaccination in patients with chronic or autoimmune rheumatic diseases: the ego, the id and the superego. Joint Bone Spine. 2012;79(1):1–3. doi:10.1016/j.jbspin.2011.10.006.PubMedCrossRef

12.

Pellegrino P, Carnovale C, Perrone V, Antoniazzi S, Pozzi M, Clementi E, et al. Can HPV immunisation cause ADEM? Two case reports and literature review. Mult Scler. 2014;20(6):762–3. doi:10.1177/1352458513502114.PubMedCrossRef

13.

Pellegrino P, Carnovale C, Perrone V, Salvati D, Gentili M, Antoniazzi S, et al. Human papillomavirus vaccine in patients with systemic lupus erythematosus. Epidemiology. 2014;25(1):155–6. doi:10.1097/EDE.0000000000000033.PubMedCrossRef

14.

Pellegrino P, Carnovale C, Perrone V, Salvati D, Gentili M, Brusadelli T, et al. On the association between human papillomavirus vaccine and primary ovarian failure. Am J Reprod Immunol. 2014;71(4):293–4. doi:10.1111/aji.12190.PubMedCrossRef

15.

Loughlin AM, Marchant CD, Adams W, Barnett E, Baxter R, Black S, et al. Causality assessment of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS). Vaccine. 2012;30(50):7253–9. doi:10.1016/j.vaccine.2012.09.074.PubMedCrossRef

16.

Harper DM, Irons BB, Alexander NM, Comes JC, Smith MS, Heutinck MA, et al. Quantifying the decisional satisfaction to accept or reject the Human Papillomavirus (HPV) vaccine: a preference for cervical cancer prevention. PLoS One. 2014;9(2):e88493. doi:10.1371/journal.pone.0088493.PubMedCentralPubMedCrossRef

17.

Szarewski A, Skinner SR, Garland SM, Romanowski B, Schwarz TF, Apter D, et al. Efficacy of the HPV-16/18 AS04-adjuvanted vaccine against low-risk HPV types (PATRICIA randomized trial): an unexpected observation. J Infect Dis. 2013;208(9):1391–6. doi:10.1093/infdis/jit360.PubMedCentralPubMedCrossRef

18.

Harper DM, Vierthaler SL. Next generation cancer protection: the bivalent HPV vaccine for females. ISRN Obstet Gynecol. 2011;2011:457204. doi:10.5402/2011/457204.PubMedCentralPubMedCrossRef

19.

Wheeler CM, Castellsague X, Garland SM, Szarewski A, Paavonen J, Naud P, et al. Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. Lancet Oncol. 2012;13(1):100–10. doi:10.1016/S1470-2045(11)70287-X.PubMedCrossRef

20.

Pellegrino P, Carnovale C, Cattaneo D, Perrone V, Antoniazzi S, Pozzi M, et al. Pharmacovigilance knowledge in family paediatricians. A survey study in Italy. Health Policy. 2013;113(1–2):216–20. doi:10.1016/j.healthpol.2013.08.006.PubMedCrossRef

21.

Blank M, Israeli E, Shoenfeld Y. When APS (Hughes syndrome) met the autoimmune/inflammatory syndrome induced by adjuvants (ASIA). Lupus. 2012;21(7):711–4. doi:10.1177/0961203312438115.PubMedCrossRef

22.

Cruz-Tapias P, Agmon-Levin N, Israeli E, Anaya JM, Shoenfeld Y. Autoimmune (auto-inflammatory) syndrome induced by adjuvants (ASIA): animal models as a proof of concept. Curr Med Chem. 2013;20(32):4030–6.PubMedCrossRef

23.

Perricone C, Colafrancesco S, Mazor RD, Soriano A, Agmon-Levin N, Shoenfeld Y. Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) 2013: unveiling the pathogenic, clinical and diagnostic aspects. J Autoimmun. 2013;47:1–16. doi:10.1016/j.jaut.2013.10.004.PubMedCrossRef

24.

Soriano A, Butnaru D, Shoenfeld Y. Long-term inflammatory conditions following silicone exposure: the expanding spectrum of the autoimmune/inflammatory syndrome induced by adjuvants (ASIA). Clin Exp Rheumatol. 2014;32(2):151–4.PubMed

25.

Pellegrino P, Carnovale C, Perrone V, Pozzi M, Antoniazzi S, Clementi E, et al. Acute disseminated encephalomyelitis onset: evaluation based on vaccine adverse events reporting systems. PLoS One. 2013;8(10):e77766. doi:10.1371/journal.pone.0077766.PubMedCentralPubMedCrossRef

26.

Pellegrino P, Carnovale C, Perrone V, Salvati D, Gentili M, Brusadelli T, et al. On the possible interaction between vaccines and drugs. Eur J Clin Pharmacol. 2014;70(3):369–71. doi:10.1007/s00228-013-1616-3.PubMedCrossRef

27.

Pellegrino P, Clementi E, Radice S. Infections, vaccinations, drugs and interactions. Eur J Clin Pharmacol. 2014;. doi:10.1007/s00228-014-1689-7.

28.

Pellegrino P, Carnovale C, Radice S, Clementi E. Influenza-like illness after yellow fever vaccination. J Clin Virol. 2014;. doi:10.1016/j.jcv.2014.03.015.PubMed

29.

Posteraro B, Pastorino R, Di Giannantonio P, Ianuale C, Amore R, Ricciardi W, et al. The link between genetic variation and variability in vaccine responses: systematic review and meta-analyses. Vaccine. 2014;32(15):1661–9. doi:10.1016/j.vaccine.2014.01.057.PubMedCrossRef

30.

Ovsyannikova IG, Jacobson RM, Poland GA. Variation in vaccine response in normal populations. Pharmacogenomics. 2004;5(4):417–27. doi:10.1517/14622416.5.4.417.PubMedCrossRef

31.

Pellegrino P, Falvella FS, Perrone V, Carnovale C, Brusadelli T, Pozzi M, et al. The first steps towards the era of personalised vaccinology: predicting adverse reactions. Pharmacogenomics J. 2014;. doi:10.1038/tpj.2014.57.PubMed

32.

Pellegrino P, Clementi E, Capuano A, Radice S. Can vaccines interact with drug metabolism? Pharmacol Res. 2014. doi:10.1016/j.phrs.2014.09.003.

33.

Pellegrino P, Carnovale C, Perrone V, Pozzi M, Antoniazzi S, Radice S, et al. Efficacy of vaccination against influenza in patients with multiple sclerosis: the role of concomitant therapies. Vaccine. 2014;32(37):4730–5. doi:10.1016/j.vaccine.2014.06.068.PubMedCrossRef

34.

Pellegrino P, Carnovale C, Borsadoli C, Danini T, Speziali A, Perrone V, et al. Two cases of hallucination in elderly patients due to a probable interaction between flu immunization and tramadol. Eur J Clin Pharmacol. 2013;69(8):1615–6. doi:10.1007/s00228-013-1517-5.PubMedCrossRef

35.

Kennedy RB, Ovsyannikova IG, Lambert ND, Haralambieva IH, Poland GA. The personal touch: strategies toward personalized vaccines and predicting immune responses to them. Expert Rev Vaccines. 2014;13(5):657–69. doi:10.1586/14760584.2014.905744.PubMedCrossRef

36.

Klein SL, Poland GA. Personalized vaccinology: one size and dose might not fit both sexes. Vaccine. 2013;31(23):2599–600. doi:10.1016/j.vaccine.2013.02.070.PubMedCrossRef

37.

Mitchell LA, Tingle AJ, MacWilliam L, Horne C, Keown P, Gaur LK, et al. HLA-DR class II associations with rubella vaccine-induced joint manifestations. J Infect Dis. 1998;177(1):5–12.PubMedCrossRef

38.

Pellegrino P, Carnovale C, Perrone V, Salvati D, Gentili M, Brusadelli T, et al. Epidemiological analysis on two decades of hospitalisations for meningitis in the United States. Eur J Clin Microbiol Infect Dis. 2014;33(9):1519–24. doi:10.1007/s10096-014-2102-2.PubMedCrossRef

39.

Karussis D, Petrou P. The spectrum of post-vaccination inflammatory CNS demyelinating syndromes. Autoimmun Rev. 2014;13(3):215–24. doi:10.1016/j.autrev.2013.10.003.PubMedCrossRef

40.

Agmon-Levin N, Paz Z, Israeli E, Shoenfeld Y. Vaccines and autoimmunity. Nat Rev Rheumatol. 2009;5(11):648–52. doi:10.1038/nrrheum.2009.196.PubMedCrossRef

41.

Agmon-Levin N, Arango MT, Kivity S, Katzav A, Gilburd B, Blank M et al. Immunization with hepatitis B vaccine accelerates SLE-like disease in a murine model. J Autoimmun. 2014. doi:10.1016/j.jaut.2014.06.006.

Title: The epidemiological profile of ASIA syndrome after HPV vaccination: an evaluation based on the Vaccine Adverse Event Reporting Systems
Authors: Paolo Pellegrino
Valentina Perrone
Marco Pozzi
Carla Carnovale
Cristiana Perrotta
Emilio Clementi
Sonia Radice
Publication date: 01-02-2015
Publisher: Springer US
Published in: Immunologic Research / Issue 1-2/2015
Print ISSN: 0257-277X
Electronic ISSN: 1559-0755
DOI: https://doi.org/10.1007/s12026-014-8567-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The epidemiological profile of ASIA syndrome after HPV vaccination: an evaluation based on the Vaccine Adverse Event Reporting Systems

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1-2/2015

Cutting edge data in autoimmunity: as presented in the 9th international congress of autoimmunity

Lupus and leprosy: beyond the coincidence

Adjuvants and lymphoma risk as part of the ASIA spectrum

Autoimmune diagnostics: the technology, the strategy and the clinical governance

Anti-CarP antibodies as promising marker to measure joint damage and disease activity in patients with rheumatoid arthritis

Erratum to: Immunoreactivity and avidity of IgG anti-β2-glycoprotein I antibodies from patients with autoimmune diseases to different peptide clusters of β2-glycoprotein I